Ethics expert: "Call time on soft approach to Big Alcohol"

Dr Carwyn Hooper, Senior Lecturer in Medical Ethics and Law at St George's, University of London, says: "Ten years ago the World Health Organisation’s Framework Convention on Tobacco Control (FCTC) came into force. It was not the first international health treaty negotiated by the WHO, but in many ways it was the most remarkable. Achieving global consensus around any kind of public health treaty is quite a feat. So achieving a consensus when the main target of the treaty was, in effect, that most slippery and dangerous of customers – Big Tobacco – was close to miraculous.

"Within a year, 168 states had signed the treaty and many more are now parties to the convention. As the WHO loudly (and rightly) trumpets, this makes it “one of the most rapidly and widely embraced treaties in the history of the United Nations”.


The science behind craving

Have you ever tried to diet or give up a bad habit? Perhaps you've tried to stop smoking or simply wondered why we desire things that are bad for us. If so, some of the answers you've been craving are in this episode of the St George's, University of London podcast.

In this podcast we talk to two of our experts about the science behind craving. Dr James Erskine, senior lecturer in psychology and behavioural medicine talks about his work with dieting and craving and asks why we often do things like over-eating when we really don't want to. His experiments with chocolate were of particular interest for this episode!


TB in Tooting

To mark World TB Day, Monday 24 March 2014 St George's, University of London has released a podcast discussing the epidemic, its impact on all of our lives and the efforts to fight it.

Dr Catherine Cosgrove of St George's, University of London and St George's NHS Healthcare Trust starts us off with a discussion of the experience of patients with TB, followed by Philip Butcher, professor of molecular medical microbiology, who discusses the relevance for Tooting and his work with genomics and the podcast finishes with Dr Amina Jindani who works on the InterTB project talks about her work on reducing the length of drug regimens and the millennial goals.